Organizational Overview: Immunovant is a clinical-stage biopharmaceutical company committed to developing innovative therapies for patients living with autoimmune diseases. We are developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneo...
IMVT Corporation
19 days ago